While our understanding of the molecular and cellular effects of COVID-19 continues to grow, it remains an urgent concern; the disease causes a variety of clinical presentations and results in a myriad of symptoms in non-hospitalized and hospitalized patients.
These investigations have widely shown that severe COVID-19 patients tend to present with broad immune dysfunction, specifically, decreased lymphocyte counts, abundant inflammation and heightened cytokine levels, delayed B cell activation and antibody production, and impaired interferon-mediated antiviral responses3–9.
Additionally, current literature describes bulk proteomic and transcriptomic signatures of neutrophil hyperactivation states in severe COVID-19 patients and suggests a unique role of neutrophils in the pathogenesis of the disease7,10–13.
An overabundance of neutrophil precursors coupled with dysfunctional mature neutrophils in the blood of severe COVID-19 patients compared to mild patients suggests that a dysregulated myeloid cell compartment is indicative of severe disease11.
Finally, multiple studies have proposed that emergency myelopoiesis, the activation of hematopoietic progenitors in the bone marrow which leads to an abundance of suppressive immature neutrophils, is a prominent feature of severe COVID-19 associated with poor prognosis11,14,15.
The observed dysregulation of the humoral immune response in severe COVID-19 patients has implications beyond immediate viral neutralization, as pathogen recognition by neutrophils is partly driven by opsonic receptors such as Fc receptors, and thus neutrophil responses may also be affected16. As of yet, the effects of dysregulated humoral responses on neutrophil effector functions is not understood.
Current literature suggests that recognition of antigen-antibody complexes by neutrophils may be important in eliciting various effector responses. The removal of pathogens by neutrophils can occur directly in a process termed antibody-dependent neutrophil phagocytosis (ADNP) in which neutrophils recognize pathogen-antibody immune complexes17,18, or through NETosis, a specialized cell death program in which neutrophils release neutrophil extracellular traps (NETs) consisting of chromatin modified with anti-microbial proteins19,20.
In the context of various pathologies such as viral infection, cancer, and heparin-induced thrombocytopenia, NETosis has been shown to be largely driven by antibody-Fc receptor interactions which can be further regulated by antibody isotype and glycosylation profile21–23.
Furthermore, protein and transcriptional signatures of neutrophil activation and degranulation in plasma and whole blood of hospitalized COVID-19 patients were predictive of increased mortality14.
While most studies on COVID-19 immunity utilize samples lacking polymorphonuclear cells (i.e. peripheral blood mononuclear cells (PBMCs)), there is a need to perform in-depth analyses of the role of neutrophil dynamics in differential COVID-19 progression in large cohorts in order to better understand the role of these cell types within the wider host immune response to SARS-CoV-2.
Here, we present a longitudinal study of enriched blood neutrophils from a large cohort of hospitalized COVID-19 patients that combines unbiased, bulk transcriptomic analysis of enriched blood neutrophils with plasma proteomics, cfDNA measurements, and high-throughput antibody profiling in order to understand neutrophil response dynamics during the immune response to SARS-CoV-2 infection.
In a scenario where patients with severe COVID-19 could develop dysfunction of the immune response that aggravates the hyperinflammation [5, 6], it is hypothesized that neutrophils can amplify pathological damage or control other cell subsets depending on the infection features. Therefore, to use the potential of NETs with minimal damage to the hosts, there must be a right balance of NET formation and reduction of the amount of NETs that accumulate in tissues .
Notwithstanding the rapid progress in the field, there are many critical unknown features of neutrophils in fighting viral infections. We highlighted the current progress in the pathways of neutrophilic inflammation in viral infection, with a focus on the release of NETs and its influence on lung disease. The knowledge summarized in this study should benefit researchers in integrating neutrophil biology to design new and more efficient virus-targeted interventions concerning COVID-19.
Although a well-regulated innate immune process is the first protection action against viral infections , in severe COVID-19 condition occurs hyperinflammation (“cytokine storm”) that might lead to the acute respiratory distress syndrome (ARDS) [6, 9].
Cytokines play a relevant function in immunopathology during virus infections. The host-viral interactions are established via host identification of pathogen-associated molecular patterns (PAMPs) of the virus . This identification occurs through host pattern recognition receptors (PRRs) manifested on innate immune cells (e.g., neutrophils, dendritic cells, epithelial cells, and macrophages) , and the recognition of PAMPs and viral danger-associated molecular patterns (DAMPs) by conserved PRRs marks the first line of defense against pathogens, involving toll-like receptors (TLRs) .
TLR stimulation activates the nuclear factor-κB (NF-κB) signaling cascade, causing the production of inflammatory markers from monocytes (interleukin- (IL-) 1, tumor necrosis factor-alpha (TNF-α), and IL-6) to control virus infections  by direct antiviral pathways and the recruitment of other leukocytes . Moreover, the exacerbated oxidative stress induced by elevated concentrations of cytokines, along with reduced concentrations of interferon α and interferon β (IFN-α, IFN-β), influences the severity of COVID-19 .
Several mediators control the release of chemoattractants and neutrophil activity , and studies have demonstrated that higher values of proinflammatory markers are related to extensive lung damage and pulmonary inflammation in MERS-CoV  and ARDS infection . COVID-19 in the severe state exhibits a cytokine storm with elevated plasma levels of chemokine ligand 2 (CCL2), IFNγ, IFNγ-inducible protein 10, G-CSF, chemokine C-C motif ligand 3 (CCL3), IL-1β, IL-2, IL-6, IL-7, IL-8, IL-10, IL-17, and TNF-α [12, 15].
Nucleotide-binding oligomerization domain- (NOD-) like receptor and increased plasma levels of chemokines and cytokines in COVID-19 patients relate to the severity of the disease rather than did those nonsevere patients . In this sense, Huang et al.  found that patients in the intensive care unit (ICU) with laboratory-confirmed COVID-19 infection had higher plasma levels of IL-2, IL-7, IL-10, interferon-inducible protein 10, granulocyte colony-stimulating factor, CCL2, CCL3, and TNF-α when compared with non-ICU patients .
Neutrophils: The First Cell Recruitment
Neutrophils are innate immune cells with a brief lifespan after leaving the bone marrow and exist in a quiescent, primed, or active state. These leukocytes are the leading players in innate immunity since they are among the first innate leukocytes recruited during infections . The primary function of neutrophil is clearance of pathogens and debris through phagocytosis . They also have a distinct array of other immune roles, such as the liberation of NETs for viral infection inactivation  and cytokine production to restrict virus replication .
The release of neutrophil-chemoattractive elements and the resulting recruitment of neutrophils are a global host response to viral infection . In this scenario, the neutrophil cell membrane also expresses a complex array of receptors and adhesion molecules for various ligands, including immunoglobulins, membrane molecules on other cells, and cytokines .
In addition to the trafficking to infection places to phagocytize viruses, the neutrophils can initiate, enlarge, and/or repress adaptive immune effector processes by promoting bidirectional cross-talk with T cells [21, 22]. Following the acute inflammation arising from immunological processes, such as viral infections, neutrophils with decreased expression of CD62L weaken T cell migration via the CXCL11 chemokine gradient by releasing H2O2 into an immunological synapse .
Thus, neutrophils that uncovered viral antigens can home to draining lymph nodes, acting as antigen-presenting cells (APC) . Hufford et al.  evidenced that neutrophils expressing viral antigen as an outcome of direct infection by influenza A virus (IAV) display the most potent APC activity and that viral antigen-presenting neutrophils infiltrating the IAV-infected lungs act as APC for effector CD8(+) T lymphocytes in the infected lungs . Neutrophils recruit the T cell molecular mechanism during the influenza virus infection and associate to CXCL12 reservoirs left behind. CD8+ T cells follow the chemoattractant trail left behind by neutrophil uropods to the influenza virus infection site .
Decreased cell number or impaired leukocyte function can play a part in advance of mild to severe clinical disease conditions . Regarding the new coronavirus, the neutrophil-to-lymphocyte ratio (NLR), a well-known marker of infection and systemic inflammation, has evidenced an enhanced inflammatory response in COVID-19 patients . Since the ARDS is the primary cause of mortality in patients with COVID-19, the elevated NLR values suggest a poor prognosis in COVID-19 disease , especially severe COVID-19 compared to mild patients. Sun et al.  studied 116 patients with COVID-19 and showed a higher NLR .
The authors compared severe COVID-19 patients admitted to the ICU with others or severe patients not admitted to the ICU. They reported that COVID-19 patients have the lowest count of lymphocytes and the highest neutrophil count and NLR . Wang et al.  also showed that several COVID-19 patients have a rising neutrophil count and a falling lymphocyte count during the severe phase .
Similarly, Barnes et al.  found extensive neutrophil infiltration in pulmonary capillaries from a COVID-19 patient . Nevertheless, even though severe cases of COVID-19 appear to be related to increased NLR levels , whether NLR could be an independent predictor of mortality in COVID-19 patients still requires investigation.
Neutrophil Extracellular Traps (NETs) and Viral Infection
Neutrophils can develop a sophisticated network of DNA called NETs through NETosis, a liberation of web-like structures of nucleic acids wrapped with histones that detain viral particles . Upon discovery, the researchers believed that the production of NETs defended only against fungi and bacteria . However, the NETosis process plays an important function in the response to viral diseases , thereby protecting the host during the virus response by trapping and eliminating distinct pathogens .
The formation of NETs is a controlled process, even though the related signals remain unknown. NETosis is conditional on the production of reactive oxygen species (ROS) by nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) . There is evidence of NETosis produced in a ROS-independent mechanism .
In general, the NETosis process includes the release of nuclear chromatin lined with effector proteins and peptidyl arginine deiminase type IV (PAD4) activation . After stimulation, the neutrophil nuclear envelope disintegrates to enable the mixing of chromatin with granular proteins . Myeloperoxidase (MPO) and neutrophil elastase (NE) stimulate chromatin condensation and deteriorate histones .
In the presence of histone hypercitrullination, PAD4 mediates chromatin decondensation, and the DNA-protein complexes are released extracellularly as NETs . Therefore, differently from apoptosis or necrosis, both the granular membrane and nuclear membrane deteriorate during NETosis, whereas plasma membrane integrity remains .
The overproduction of NETs induces lung tissue damage by NETosis-related enzymes such as NE and MPO . Uncontrolled NET production correlates with disease gravity and lung injury extension. For instance, NETosis markers are related to bacterial burden and local inflammation in the lung  and patients with pneumonia-associated ARDS have neutrophils in a “primed” condition to generate NETs .
During chronic obstructive pulmonary disease aggravation, the production of NETs increases in people with acute respiratory failure  and in ARDS patients [40, 42]. The elevated NET production, as noted in patients with severe IAV infection , increased injury to the pulmonary endothelial and epithelial cells , directing to severe pneumonia. Zhu et al.  also noted that the production of NETs positively correlates with multiple organ dysfunction syndromes .
The inflammatory process is a trigger for thrombotic complications usually noted in COVID-19 patients, and the immunothrombotic dysregulation seems to be an important key marker for the disease severity . Skendros et al.  found that complement activation potentiates the platelet/NET/tissue factor/thrombin axis during SARS-CoV-2 infection .
In contrast, Nicolai et al.  noted that, in COVID-19, inflammatory microvascular thrombi are found in the kidney, lung, and heart, containing NETs related to the fibrin and platelets. In blood, Nicolai et al. also show that COVID-19 patients have neutrophil-platelet aggregates and a different platelet and neutrophil activation pattern, which alters with the disease severity .
Middleton et al.  also found that plasma MPO-DNA complexes increased in COVID-19 and that the elevated NET formation correlates with COVID-19-related ARDS. Together, these findings suggest the timely application of therapeutic strategies that can disrupt the vicious cycle of COVID-19 immunothrombosis/thromboinflammation by targeting neutrophil activation and NET formation.
In addition to the physical containment promoted by NETosis , NETs contain DNA, modified extracellular histones, proteases, and cytotoxic enzymes that allow neutrophils to centralize lethal proteins at infection sites . The mechanisms of NETs’ release in the viral response seem to involve neutrophil NE production attributed to the change of macrophage role by the cleavage of TLRs . A range of stimuli, including toxic factors, viruses, and proinflammatory cytokines, such as TNF-α and IL-8, can lead neutrophils to release NETs [7, 33]. Mechanisms that determine strain specificity to induce NETosis formation during viral infection are still unknown.
Lung inflammation is the leading cause of the life-threatening respiratory complication at the severe levels of COVID-19 . Veras et al.  investigated the potentially detrimental function of NETs in the pathophysiology of 32 hospitalized severe COVID-19 patients and found that the levels of NETs increase in tracheal aspirate and plasma from patients with COVID-19 and their neutrophils naturally produced more significant concentrations of NETs .
The authors also reported NETs in the lung tissue specimens from autopsies of COVID-19 patients. In vitro, they noted that viable SARS-CoV-2 cause NET production by healthy neutrophils through a PAD-4-dependent manner and that NETs produced by SARS-CoV-2-activated neutrophils instigated lung epithelial cell death . Zuo et al.  also investigated sera from COVID-19 patients and found higher cell-free DNA, myeloperoxidase-DNA (MPO-DNA), and citrullinated histone H3 (Cit-H3) . In vitro, they also noted that sera from COVID-19 patients trigger NET release from control neutrophils .
Although the literature does not report direct evidence linking NETs and SARS-CoV2 clearance, virus entrapping by NETs was already found in syncytial respiratory virus infection  or influenza . Furthermore, in virus infection, NETs are efficient to block viruses at the infection site, entrapping them in a DNA web .
Therefore, the NETosis process induced by the virus could operate as a double-edged sword: on the one hand, there are essential and efficient mechanisms for trapping the virus , and on the other, there are highly intense immunological and inflammatory processes triggered by NET release causing damage to the organism . These interactions could influence the COVID-19 symptoms in the relationship between hyperinflammation (overproduction of NETs and cytokine storm) and the function of neutrophils to destroy the viral infection (Figure 1).
reference link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732408/
reference link : https://www.biorxiv.org/content/10.1101/2021.10.04.463121v1.full